From the Eye of the Storm to Epidemiological Footprints After the Floods: Viral, Vector-Borne, and One Health Risks Post-Hurricane Melissa in Jamaica. [PDF]
Douglas KO, Ranglin-Edwards G.
europepmc +1 more source
Evidence of a putative new species Haemagogus 'Trinidad sp. A' from the Caribbean sharing mitogenome lineages with species endemic to the Amazon. [PDF]
Ali RLMN +8 more
europepmc +1 more source
A cluster of Mayaro virus infections in a film team returning from Suriname, February 2024. [PDF]
Orth HM +10 more
europepmc +1 more source
Exposure to non-endemic arboviruses (alphaviruses) in Costa Rica assessed from human samples collected in areas with contrasting levels of dengue endemicity. [PDF]
Valles-Morera A +9 more
europepmc +1 more source
Correction: Gajurel et al. Arbovirus in Solid Organ Transplants: A Narrative Review of the Literature. <i>Viruses</i> 2024, <i>16</i>, 1778. [PDF]
Gajurel K, Dhakal R, Deresinski S.
europepmc +1 more source
Rapid differentiation of VLA1553 and wild-type ECSA chikungunya strains in the context of an IXCHIQ vaccination campaign. [PDF]
Pezzi L +14 more
europepmc +1 more source
The CRISPR-Cas toolkit for mosquito-borne virus surveillance: detection, tracing, and discovery. [PDF]
Wu Y +10 more
europepmc +1 more source
Mayaro virus fever: a necessary alert
openaire +1 more source
Mayaro Virus Pathogenesis and Transmission Mechanisms [PDF]
Mayaro virus (MAYV), isolated for the first time in Trinidad and Tobago, has captured the attention of public health authorities worldwide following recent outbreaks in the Americas. It has a propensity to be exported outside its original geographical range, because of the vast distribution of its vectors.
Rodolphe Hamel +2 more
exaly +6 more sources
Repurposing Drugs for Mayaro Virus: Identification of EIDD-1931, Favipiravir and Suramin as Mayaro Virus Inhibitors [PDF]
Despite the emerging threat of the Mayaro virus (MAYV) in Central and South-America, there are no licensed antivirals or vaccines available for this neglected mosquito-borne virus. Here, we optimized a robust antiviral assay based on the inhibition of the cytopathogenic effect that could be used for high-throughput screening to identify MAYV inhibitors.
Lana Langendries +2 more
exaly +4 more sources

